新冠疫苗接种异常反应的补偿机制  

Compensation mechanism of abnormal reaction for COVID-19 vaccination

作　　者：高娜 王伟伟[2] Gao Na;Wang Weiwei(Administrators training center of the National Health Commission of the PRC(Party school of the NationalHealth Commission of the PRC),Beijing 100024,China;Institute of law,Beijing Academy of Social Sciences,Beijing 100101,China)

机构地区：[1]国家卫生健康委干部培训中心(国家卫生健康委党校),北京100024 [2]北京市社会科学院法治研究所,北京100101

出　　处：《中国卫生法制》2022年第4期52-55,63,共5页China Health Law

基　　金：北京市社会科学院一般项目“无体财产财产权的归属与流转规则研究”(01193041)。

摘　　要：我国区分免疫规划疫苗和非免疫规划疫苗,两者实行不同的预防接种异常反应补偿机制。新冠疫苗是否及如何纳入免疫规划疫苗,由国家卫健委报国务院作出决定。如将新冠疫苗明确为免疫规划疫苗,则由省级人民政府按照既有的法定补偿机制办理,也可专设特别的补偿机制。如将新冠疫苗纳入非免疫规划疫苗,则由疫苗上市许可持有人承担异常反应的补偿,并可通过政府采购合同、商业保险等完善补偿机制。新冠疫苗预防接种异常反应补偿机制的完善,有利于为新冠疫苗接种提供制度保障。In China,there are different compensation mechanisms for abnormal vaccination reactions between immunization program vaccines and non immunization program vaccines.The National Health Commission shoulders the power to report to the State Council for a decision on whether COVID-19 vaccine should be included in the immunization program.If the COVID-19 vaccine is included in the vaccines under immunization program system,the provincial governments are responsible to compensate the inoculated subjects suffered abnormal reaction,which according to the existing legal compensation mechanism,or to set up a special compensation mechanism.If the COVID-19 vaccine is included in the non immunization program,the vaccine marketing license holders shall bear the compensation for the abnormal reaction,and the compensation mechanism can be improved through government procurement contract and commercial insurance.The erection and improvement of the compensation mechanism of abnormal reaction in COVID-19 vaccination is an institutional guarantee for COVID-19 vaccination.

关 键 词：新冠疫苗 异常反应 补偿机制 

分 类 号：D902[政治法律—法学理论]